Pages

Monday, May 3, 2021

OCGN - Ocugen Extremely Strong in a Hot Vaccine Market

Ocugen closed a $100 Million Offering last week and has continued to trade higher. The chart is incredibly strong with a large scale expanding pattern. OCGN is wide open to the upside. Price is very aggressively channelling higher. Any comparable with a viable Covid-19 vaccine is trading at far greater prices. The United Stated is in a mass vaccination program currently. Everybody is thinking and talking about vaccines, therefore, the vaccine market is red hot at this time. India is experiencing a Covid outbreak that is rampant and will overwhelm the hospital system shortly... Daily

32 comments:

  1. "MALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. As previously disclosed, a study conducted by ICMR also suggested that COVAXIN was effective against the UK variant, B.1.1.7, as well as the Indian double mutant variant, B.1.617. It is notable that the Brazilian variant, B1.128.2, contains the E484K mutation that was found in New York.

    In the ICMR studies, COVAXIN-vaccinated sera effectively neutralized several SARS-CoV-2 variants (B.1.617 (India, double mutant), B.1.1.7 (United Kingdom), B.1.1.28 (Brazil P2), and heterologous strain) in an in-vitro plaque reduction neutralization assay. These studies suggest that COVAXIN vaccination may be effective against multiple SARS-CoV-2 variants."

    ReplyDelete
  2. News gapping OCGN higher this morning. The gap is likely to fill actually, but a lot of strength regardless.

    ReplyDelete
  3. I look forward to the inferms as covid vaccines revive the dead

    ReplyDelete
  4. sc,

    new chart---new page-----are you still holding UVXY--from the previous chart ---???

    ReplyDelete
  5. OCGN hasn't even had a decent down day on this run. I think it is coming soon. Taking profits seems to be the right choice.

    ReplyDelete
  6. SC,
    Are you holding through the UVXY r/s? Does it affect your targets at all?

    ReplyDelete
    Replies
    1. The volatility is coming but what makes this a challenge for UVXY is that the VIX futures are in contango.

      http://vixcentral.com/

      Delete
    2. The rs doesn't bother me but contango is a battle. I'm going to review.

      Delete
  7. Sc
    So you have any charts on cryptos ?

    ReplyDelete
    Replies
    1. We're getting closer to launching a bitcoin etf in the US. This is going to be an important event.

      Delete
  8. Oil update coming also. Looking good.

    ReplyDelete
  9. Replies
    1. Look to enter again soon. After split.

      Delete
    2. Do you know when they are supposed to split. I can't seem to find anything. Just this article on https://sixfigureinvesting.com/2014/01/uvxy-reverse-split/

      Delete
    3. SC,
      Do you have a price target? Under $40 for uvxy?

      Delete
    4. UVXY reverse split tomorrow

      Delete
    5. Let's update charts after split tomorrow.

      Delete
  10. sc,

    VIX is at 20 again--???

    Yellin--speaks Friday

    Good Day to-short?

    ReplyDelete
  11. sc,

    where are you looking to buy OCGN back ---what level?

    ReplyDelete
    Replies
    1. I'm waiting for the dust to settle. OCGN 50 day is at $8.67.

      Delete
  12. Hold off on OCGN until XBI covers gap at 115....its going to do it in next 2 days by looks of it...ultimately XBI could go to 95....I would load up huge there....

    LABD to short it on way down, should accelerate in final move to 38

    ReplyDelete
    Replies
    1. Yes selling off. XBI not oversold yet. I see the previous high for OCGN $18 in February also coincides with the high in XBI in February.

      Delete
  13. Yes the whole complex is selling off. I see Novavax NVAX is getting hit too. News sparked some selling:

    "U.S. backs waiving patent protections for Covid vaccines, citing global health crisis"

    ReplyDelete
    Replies
    1. "Stocks of major pharmaceutical companies that have produced vaccines, including Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke. Pfizer ended its trading day flat, while Moderna lost 6.1%; Johnson & Johnson shed a modest 0.4%."

      Delete
  14. Some confusion on UVXY split. Proshares put out press release on April 22 showing UVXY 10 for 1 reverse split but the dates are wrong on the announcement.

    So we assume a split is coming but not sure which day.

    ReplyDelete